相关实验视频

Updated: Jun 13, 2025

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

比瓦利鲁丁在体外膜氧化中的作用

Sabrina Dunham¹, Patrick M Wieruszewski^2,3, James E Gerrald⁴

¹Department of Pharmacy Services, University of Michigan Health, Ann Arbor, MI.

Journal of cardiovascular pharmacology

|September 11, 2024

概括

比瓦利鲁丁是一种直接的血栓激素抑制剂,与肝素相比,它可能在体外膜氧化 (ECMO) 中提供更好的安全性和有效性. 这次审查强调了比瓦利鲁丁.

科学领域:

心血管医学心血管医学
血液学血液学血液学
关键护理医学关键护理医学

背景情况:

体外膜氧化 (ECMO) 对耐火性心脏/肺衰竭至关重要.
出血和血栓形成是严重的并发症,需要仔细的抗凝管理.
通常使用的氨酸具有局限性,包括氨酸诱导的血小板缩和耐药性.

研究的目的:

审查在ECMO中使用比瓦利鲁丁的证据.
为了比较比瓦利鲁丁对肝素的安全性和有效性.
讨论在ECMO中实施比瓦利鲁丁的实际考虑.

主要方法:

在ECMO中对比瓦利鲁丁研究的文献综述.
分析与血栓形成,出血和抗凝血相关的结果.
讨论临床考虑和挑战.

主要成果:

比瓦利鲁丁在减少电路血栓形成和出血事件方面显示出有利的结果.
改善了用bivalirudin观察到的剂量可靠性和减少了血液产品的利用.
在ECMO脱管成功和患者存活率的积极趋势.

结论:

比瓦利鲁丁为ECMO抗凝剂提供了对肝素的潜在优势替代品.
它可以通过提高安全性和可靠性来简化ECMO管理.
对特定的临床情景进行进一步调查是有必要的.

更多相关视频

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...